TreeWAS – Variant ID: rs4711092

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
K90.0 Coeliac disease	1.000	0.000	0.000
T42.4 Benzodiazepines	0.000	0.579	0.421
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.602	0.398
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.604	0.396
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.667	0.333
T42.1 Iminostilbenes	0.000	0.703	0.297
K90 Intestinal malabsorption	0.286	0.714	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.714	0.286
T42.2 Succinimides and oxazolidinediones	0.000	0.714	0.286
T42.3 Barbiturates	0.000	0.727	0.273
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.746	0.254
T42.0 Hydantoin derivatives	0.000	0.757	0.243
K90.8 Other intestinal malabsorption	0.237	0.763	0.000
K90.3 Pancreatic steatorrhoea	0.205	0.795	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.205	0.795	0.000
K90.1 Tropical sprue	0.205	0.795	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.142	0.858	0.000
K90.9 Intestinal malabsorption, unspecified	0.141	0.859	0.000
H43 Disorders of vitreous body	0.101	0.899	0.000
H43.8 Other disorders of vitreous body	0.096	0.904	0.000
H43.1 Vitreous haemorrhage	0.096	0.904	0.000
H43.9 Disorder of vitreous body, unspecified	0.093	0.907	0.000
H43.3 Other vitreous opacities	0.091	0.909	0.000
H43.0 Vitreous prolapse	0.087	0.913	0.000
H43.2 Crystalline deposits in vitreous body	0.077	0.923	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.950	0.050
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.950	0.050
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.951	0.049
E83 Disorders of mineral metabolism	0.000	0.958	0.042
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.959	0.041
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.960	0.040
T50.4 Drugs affecting uric acid metabolism	0.000	0.961	0.039
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.962	0.038
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.962	0.038
T50.7 Analeptics and opioid receptor antagonists	0.000	0.964	0.036
T50.5 Appetite depressants	0.000	0.964	0.036
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.964	0.036
T50.1 Loop [high-ceiling] diuretics	0.000	0.964	0.036
T50.0 Mineralocorticoids and their antagonists	0.000	0.964	0.036
T50.8 Diagnostic agents	0.000	0.964	0.036
H43-H45 Disorders of vitreous body and globe	0.036	0.964	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.964	0.036
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.966	0.034
T36 Poisoning by systemic antibiotics	0.000	0.966	0.033
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.967	0.033
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.967	0.033
D37.1 Stomach	0.000	0.968	0.032
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.968	0.031
T45.0 Antiallergic and antiemetic drugs	0.000	0.968	0.031
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.969	0.031
E83.8 Other disorders of mineral metabolism	0.000	0.969	0.031
E83.2 Disorders of zinc metabolism	0.000	0.969	0.031
E83.0 Disorders of copper metabolism	0.000	0.969	0.031
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.969	0.031
T45.2 Vitamins, not elsewhere classified	0.000	0.970	0.030
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.971	0.029
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.971	0.029
T45.8 Other primarily systemic and haematological agents	0.000	0.971	0.029
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.971	0.029
T45.6 Fibrinolysis-affecting drugs	0.000	0.971	0.029
T45.4 Iron and its compounds	0.000	0.971	0.029
T45.3 Enzymes, not elsewhere classified	0.000	0.971	0.029
T45.5 Anticoagulants	0.000	0.971	0.029
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.971	0.028
D37.5 Rectum	0.000	0.972	0.028
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.973	0.027
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.973	0.027
T47.7 Emetics	0.000	0.973	0.027
T47.6 Antidiarrhoeal drugs	0.000	0.973	0.027
T47.5 Digestants	0.000	0.973	0.027
T47.3 Saline and osmotic laxatives	0.000	0.973	0.027
T47.2 Stimulant laxatives	0.000	0.973	0.027
T47.0 Histamine H(2)-receptor antagonists	0.000	0.973	0.027
D37.0 Lip, oral cavity and pharynx	0.000	0.974	0.026
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.026	0.974	0.000
T47.4 Other laxatives	0.000	0.974	0.026
T49.9 Topical agent, unspecified	0.000	0.974	0.026
T49.8 Other topical agents	0.000	0.974	0.026
T49.7 Dental drugs, topically applied	0.000	0.974	0.026
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.974	0.026
T49.5 Ophthalmological drugs and preparations	0.000	0.974	0.026
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.974	0.026
T49.3 Emollients, demulcents and protectants	0.000	0.974	0.026
T49.2 Local astringents and local detergents	0.000	0.974	0.026
T49.1 Antipruritics	0.000	0.974	0.026
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.974	0.026
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.974	0.026
D37.7 Other digestive organs	0.000	0.974	0.026
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.974	0.025
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.975	0.025
T48.5 Anti-common-cold drugs	0.000	0.975	0.025
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.975	0.025
T43.2 Other and unspecified antidepressants	0.000	0.975	0.025
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.976	0.024
T37.5 Antiviral drugs	0.000	0.976	0.024
T37.4 Anthelminthics	0.000	0.976	0.024
T37.3 Other antiprotozoal drugs	0.000	0.976	0.024
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.976	0.024
T37.1 Antimycobacterial drugs	0.000	0.976	0.024
T37.0 Sulphonamides	0.000	0.976	0.024
T36.9 Systemic antibiotic, unspecified	0.000	0.976	0.024
T36.8 Other systemic antibiotics	0.000	0.976	0.024
T36.7 Antifungal antibiotics, systemically used	0.000	0.976	0.024
T36.6 Rifamycins	0.000	0.976	0.024
T36.5 Aminoglycosides	0.000	0.976	0.024
T36.4 Tetracyclines	0.000	0.976	0.024
T36.3 Macrolides	0.000	0.976	0.024
T36.2 Chloramphenicol group	0.000	0.976	0.024
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.976	0.024
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.976	0.024
T48.4 Expectorants	0.000	0.976	0.024
T48.3 Antitussives	0.000	0.976	0.024
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.976	0.024
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.976	0.024
T48.0 Oxytocic drugs	0.000	0.976	0.024
D37.9 Digestive organ, unspecified	0.000	0.976	0.024
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.976	0.024
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.976	0.024
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.976	0.024
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.976	0.024
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.976	0.024
T44.0 Anticholinesterase agents	0.000	0.976	0.024
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.976	0.024
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.976	0.023
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.976	0.023
T41.5 Therapeutic gases	0.000	0.977	0.023
T41.4 Anaesthetic, unspecified	0.000	0.977	0.023
T41.3 Local anaesthetics	0.000	0.977	0.023
T41.1 Intravenous anaesthetics	0.000	0.977	0.023
T41.0 Inhaled anaesthetics	0.000	0.977	0.023
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.977	0.023
H44 Disorders of globe	0.023	0.977	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.978	0.022
D37.6 Liver, gallbladder and bile ducts	0.000	0.978	0.022
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.978	0.022
T36.0 Penicillins	0.000	0.978	0.022
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.979	0.021
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.979	0.021
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.980	0.020
T39.0 Salicylates	0.000	0.980	0.020
K90-K93 Other diseases of the digestive system	0.020	0.980	0.000
D45 Polycythaemia vera	0.000	0.980	0.020
D37.2 Small intestine	0.000	0.981	0.019
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.981	0.019
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.019	0.981	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.019	0.981	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.019	0.981	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.981	0.019
T39.4 Antirheumatics, not elsewhere classified	0.000	0.981	0.019
T39.2 Pyrazolone derivatives	0.000	0.981	0.019
H44.8 Other disorders of globe	0.019	0.981	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.981	0.018
T41.2 Other and unspecified general anaesthetics	0.000	0.982	0.018
E83.3 Disorders of phosphorus metabolism	0.000	0.982	0.018
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.982	0.017
H44.4 Hypotony of eye	0.017	0.983	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.983	0.017
T38.7 Androgens and anabolic congeners	0.000	0.983	0.017
T38.5 Other oestrogens and progestogens	0.000	0.983	0.017
T38.4 Oral contraceptives	0.000	0.983	0.017
T38.2 Antithyroid drugs	0.000	0.983	0.017
T38.0 Glucocorticoids and synthetic analogues	0.000	0.983	0.017
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.983	0.017
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.983	0.017
D37.3 Appendix	0.000	0.983	0.016
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.983	0.016
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.983	0.016
T46.7 Peripheral vasodilators	0.000	0.983	0.016
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.983	0.016
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.983	0.016
H44.6 Retained (old) intraocular foreign body, magnetic	0.016	0.984	0.000
H44.3 Other degenerative disorders of globe	0.016	0.984	0.000
H44.9 Disorder of globe, unspecified	0.016	0.984	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.984	0.016
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.016	0.984	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.984	0.016
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.985	0.015
H44.1 Other endophthalmitis	0.015	0.985	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.985	0.015
T38.1 Thyroid hormones and substitutes	0.000	0.985	0.015
D37-D48 Neoplasms of uncertain or unknown behaviour	0.000	0.985	0.015
H44.0 Purulent endophthalmitis	0.015	0.985	0.000
H44.5 Degenerated conditions of globe	0.015	0.985	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.985	0.015
T43.9 Psychotropic drug, unspecified	0.000	0.985	0.015
D64.9 Anaemia, unspecified	0.015	0.985	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.015	0.985	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.986	0.014
H44.2 Degenerative myopia	0.013	0.987	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.987	0.013
T43.6 Psychostimulants with abuse potential	0.000	0.987	0.012
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.000	0.987	0.013
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.000	0.987	0.013
D37.4 Colon	0.000	0.988	0.012
T18.1 Foreign body in oesophagus	0.012	0.988	0.000
D44.4 Craniopharyngeal duct	0.000	0.988	0.012
D38.1 Trachea, bronchus and lung	0.000	0.988	0.012
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.989	0.011
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.000	0.989	0.011
D38.0 Larynx	0.000	0.989	0.011
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.011	0.989	0.000
K93.1 Megacolon in Chagas' disease	0.011	0.989	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.011	0.989	0.000
T40.5 Cocaine	0.000	0.989	0.011
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.989	0.010
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.989	0.010
T40.8 Lysergide [LSD]	0.000	0.989	0.010
T40.7 Cannabis (derivatives)	0.000	0.989	0.010
T40.3 Methadone	0.000	0.989	0.010
T40.0 Opium	0.000	0.989	0.010
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.000	0.990	0.010
D44.8 Pluriglandular involvement	0.000	0.990	0.010
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.000	0.990	0.010
T46.1 Calcium-channel blockers	0.000	0.990	0.010
E10 Insulin-dependent diabetes mellitus	0.010	0.990	0.000
K51.8 Other ulcerative colitis	0.000	0.990	0.010
K51 Ulcerative colitis	0.000	0.990	0.010
T18 Foreign body in alimentary tract	0.010	0.990	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.010	0.990	0.000
K51.5 Mucosal proctocolitis	0.000	0.990	0.010
T40.1 Heroin	0.000	0.990	0.009
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.010	0.990	0.000
D44.0 Thyroid gland	0.000	0.991	0.009
D38.6 Respiratory organ, unspecified	0.000	0.991	0.009
D38.4 Thymus	0.000	0.991	0.009
D38.2 Pleura	0.000	0.991	0.009
E10.3 With ophthalmic complications	0.009	0.991	0.000
D44.9 Endocrine gland, unspecified	0.000	0.991	0.009
D44.5 Pineal gland	0.000	0.991	0.009
D44.2 Parathyroid gland	0.000	0.991	0.009
D44.1 Adrenal gland	0.000	0.991	0.009
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.991	0.009
E10.9 Without complications	0.009	0.991	0.000
T40.6 Other and unspecified narcotics	0.000	0.991	0.009
D44.7 Aortic body and other paraganglia	0.000	0.991	0.009
K51.4 Pseudopolyposis of colon	0.000	0.991	0.009
T18.5 Foreign body in anus and rectum	0.009	0.991	0.000
D44.6 Carotid body	0.000	0.991	0.009
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.000	0.991	0.009
E10.4 With neurological complications	0.009	0.991	0.000
D48.5 Skin	0.000	0.991	0.009
E10.8 With unspecified complications	0.009	0.991	0.000
E10.1 With ketoacidosis	0.008	0.992	0.000
E10.6 With other specified complications	0.008	0.992	0.000
D38.3 Mediastinum	0.000	0.992	0.008
D42.9 Meninges, unspecified	0.000	0.992	0.008
D42.1 Spinal meninges	0.000	0.992	0.008
D42.0 Cerebral meninges	0.000	0.992	0.008
T18.3 Foreign body in small intestine	0.008	0.992	0.000
D48.7 Other specified sites	0.000	0.992	0.008
E10.5 With peripheral circulatory complications	0.008	0.992	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.000	0.992	0.008
E10.0 With coma	0.008	0.992	0.000
D39.7 Other female genital organs	0.000	0.992	0.008
D48.4 Peritoneum	0.000	0.992	0.008
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.992	0.008
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.000	0.992	0.008
D41.4 Bladder	0.000	0.992	0.008
D44.3 Pituitary gland	0.000	0.992	0.008
E10.2 With renal complications	0.008	0.992	0.000
D39.9 Female genital organ, unspecified	0.000	0.992	0.007
D39.2 Placenta	0.000	0.992	0.007
H72 Perforation of tympanic membrane	0.000	0.992	0.008
D48.3 Retroperitoneum	0.000	0.992	0.007
D48.0 Bone and articular cartilage	0.000	0.992	0.008
T18.2 Foreign body in stomach	0.007	0.992	0.000
D38.5 Other respiratory organs	0.000	0.992	0.007
D64 Other anaemias	0.007	0.993	0.000
T18.8 Foreign body in other and multiple parts of alimentary tract	0.007	0.993	0.000
T18.4 Foreign body in colon	0.007	0.993	0.000
E10.7 With multiple complications	0.007	0.993	0.000
T18.9 Foreign body in alimentary tract, part unspecified	0.007	0.993	0.000
D39.0 Uterus	0.000	0.993	0.007
T18.0 Foreign body in mouth	0.007	0.993	0.000
T40.4 Other synthetic narcotics	0.000	0.993	0.007
D41.2 Ureter	0.000	0.993	0.007
D41.9 Urinary organ, unspecified	0.000	0.993	0.007
D41.7 Other urinary organs	0.000	0.993	0.007
D41.3 Urethra	0.000	0.993	0.007
H35.4 Peripheral retinal degeneration	0.007	0.993	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.993	0.007
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.993	0.007
D40.7 Other male genital organs	0.000	0.993	0.007
D39.1 Ovary	0.000	0.993	0.007
E21.0 Primary hyperparathyroidism	0.007	0.993	0.000
D40.9 Male genital organ, unspecified	0.000	0.993	0.006
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.000	0.993	0.007
D41.1 Renal pelvis	0.000	0.993	0.006
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.994	0.006
D40.1 Testis	0.000	0.994	0.006
H72.2 Other marginal perforations of tympanic membrane	0.000	0.994	0.006
H72.1 Attic perforation of tympanic membrane	0.000	0.994	0.006
Q63.0 Accessory kidney	0.000	0.994	0.006
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.994	0.006
N72 Inflammatory disease of cervix uteri	0.006	0.994	0.000
D64.4 Congenital dyserythropoietic anaemia	0.005	0.994	0.000
D64.3 Other sideroblastic anaemias	0.005	0.994	0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.005	0.994	0.000
D64.1 Secondary sideroblastic anaemia due to disease	0.005	0.994	0.000
D64.0 Hereditary sideroblastic anaemia	0.005	0.994	0.000
T40.2 Other opioids	0.000	0.994	0.006
E21.3 Hyperparathyroidism, unspecified	0.006	0.994	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.994	0.005
T15-T19 Effects of foreign body entering through natural orifice	0.005	0.995	0.000
D64.8 Other specified anaemias	0.005	0.995	0.000
Q63 Other congenital malformations of kidney	0.000	0.995	0.005
D43.0 Brain, supratentorial	0.000	0.995	0.005
D43.9 Central nervous system, unspecified	0.000	0.995	0.005
D43.7 Other parts of central nervous system	0.000	0.995	0.005
D43.3 Cranial nerves	0.000	0.995	0.005
T39.1 4-Aminophenol derivatives	0.000	0.995	0.005
D48.6 Breast	0.000	0.995	0.005
H72.0 Central perforation of tympanic membrane	0.000	0.995	0.005
D40.0 Prostate	0.000	0.995	0.004
T19 Foreign body in genito-urinary tract	0.005	0.995	0.000
D48.1 Connective and other soft tissue	0.000	0.995	0.005
H35.0 Background retinopathy and retinal vascular changes	0.005	0.995	0.000
D46 Myelodysplastic syndromes	0.000	0.995	0.004
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.005	0.995	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.995	0.005
H65.3 Chronic mucoid otitis media	0.000	0.995	0.005
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.995	0.005
D43.1 Brain, infratentorial	0.000	0.995	0.004
N48.4 Impotence of organic origin	0.000	0.995	0.005
Q63.2 Ectopic kidney	0.000	0.995	0.004
T17 Foreign body in respiratory tract	0.004	0.995	0.000
W44.0 Home	0.004	0.996	0.000
H65 Nonsuppurative otitis media	0.000	0.996	0.004
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.004	0.996	0.000
M89.9 Disorder of bone, unspecified	0.000	0.996	0.004
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.996	0.004
T19.0 Foreign body in urethra	0.004	0.996	0.000
H65.2 Chronic serous otitis media	0.000	0.996	0.004
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.996	0.004
Q63.3 Hyperplastic and giant kidney	0.000	0.996	0.004
M89.98 Disorder of bone, unspecified (Other)	0.000	0.996	0.004
H35 Other retinal disorders	0.004	0.996	0.000
T15 Foreign body on external eye	0.004	0.996	0.000
Q63.8 Other specified congenital malformations of kidney	0.000	0.996	0.004
T17.5 Foreign body in bronchus	0.004	0.996	0.000
K91.5 Postcholecystectomy syndrome	0.004	0.996	0.000
D41.0 Kidney	0.000	0.996	0.004
T16 Foreign body in ear	0.004	0.996	0.000
T19.1 Foreign body in bladder	0.004	0.996	0.000
D43.4 Spinal cord	0.001	0.996	0.003
N32.9 Bladder disorder, unspecified	0.004	0.996	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.000	0.996	0.004
D43.2 Brain, unspecified	0.000	0.996	0.003
T19.9 Foreign body in genito-urinary tract, part unspecified	0.004	0.996	0.000
T19.8 Foreign body in other and multiple parts of genito-urinary tract	0.004	0.996	0.000
T19.3 Foreign body in uterus [any part]	0.004	0.996	0.000
T19.2 Foreign body in vulva and vagina	0.004	0.996	0.000
K91.1 Postgastric surgery syndromes	0.004	0.996	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.996	0.004
T17.2 Foreign body in pharynx	0.004	0.996	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.004	0.996	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.996	0.004
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.000	0.996	0.003
D46.5 Refractory anaemia with multi-lineage dysplasia	0.000	0.996	0.003
D46.3 Refractory anaemia with excess of blasts with transformation	0.000	0.996	0.003
D46.1 Refractory anaemia with sideroblasts	0.000	0.996	0.003
D46.0 Refractory anaemia without sideroblasts, so stated	0.000	0.996	0.003
K91.9 Postprocedural disorder of digestive system, unspecified	0.004	0.996	0.000
T17.3 Foreign body in larynx	0.003	0.996	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.000	0.996	0.003
E21.2 Other hyperparathyroidism	0.003	0.996	0.000
H35.8 Other specified retinal disorders	0.004	0.996	0.000
T17.8 Foreign body in other and multiple parts of respiratory tract	0.003	0.996	0.000
T17.4 Foreign body in trachea	0.003	0.996	0.000
T17.1 Foreign body in nostril	0.003	0.996	0.000
T17.0 Foreign body in nasal sinus	0.003	0.996	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.003	0.997	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.997	0.003
K51.9 Ulcerative colitis, unspecified	0.000	0.997	0.003
M50.1 Cervical disk disorder with radiculopathy	0.000	0.997	0.003
M89.99 Disorder of bone, unspecified (Site unspecified)	0.000	0.997	0.003
M89.93 Disorder of bone, unspecified (Forearm)	0.000	0.997	0.003
M89.90 Disorder of bone, unspecified (Multiple sites)	0.000	0.997	0.003
K91.0 Vomiting following gastro-intestinal surgery	0.003	0.997	0.000
M34.9 Systemic sclerosis, unspecified	0.003	0.997	0.000
H35.7 Separation of retinal layers	0.003	0.997	0.000
D46.4 Refractory anaemia, unspecified	0.000	0.997	0.003
E83.5 Disorders of calcium metabolism	0.000	0.997	0.003
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.997	0.003
H35.3 Degeneration of macula and posterior pole	0.003	0.997	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.000	0.997	0.003
E21.4 Other specified disorders of parathyroid gland	0.003	0.997	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.003	0.997	0.000
T15.0 Foreign body in cornea	0.003	0.997	0.000
D46.2 Refractory anaemia with excess of blasts	0.000	0.997	0.003
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.003	0.997	0.000
T15.1 Foreign body in conjunctival sac	0.003	0.997	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.003	0.997	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.003	0.997	0.000
H35.1 Retinopathy of prematurity	0.003	0.997	0.000
T15.8 Foreign body in other and multiple parts of external eye	0.003	0.997	0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.000	0.997	0.003
D46.7 Other myelodysplastic syndromes	0.000	0.997	0.003
D75.1 Secondary polycythaemia	0.000	0.997	0.003
H65.1 Other acute nonsuppurative otitis media	0.000	0.997	0.003
M34.1 CR(E)ST syndrome	0.003	0.997	0.000
H65.0 Acute serous otitis media	0.000	0.997	0.003
T17.9 Foreign body in respiratory tract, part unspecified	0.003	0.997	0.000
H35.5 Hereditary retinal dystrophy	0.003	0.997	0.000
T15.9 Foreign body on external eye, unspecified	0.003	0.997	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.003	0.997	0.000
G51.0 Bell's palsy	0.003	0.997	0.000
M34 Systemic sclerosis	0.003	0.997	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.000	0.997	0.003
O34.2 Maternal care due to uterine scar from previous surgery	0.003	0.997	0.000
E10-E14 Diabetes mellitus	0.003	0.997	0.000
C15.4 Middle third of oesophagus	0.003	0.997	0.000
D62 Acute posthaemorrhagic anaemia	0.003	0.997	0.000
M34.8 Other forms of systemic sclerosis	0.003	0.997	0.000
L08 Other local infections of skin and subcutaneous tissue	0.002	0.997	0.000
D60-D64 Aplastic and other anaemias	0.003	0.997	0.000
K91.3 Postoperative intestinal obstruction	0.002	0.998	0.000
R85.5 Abnormal microbiological findings	0.002	0.998	0.000
H35.6 Retinal haemorrhage	0.002	0.998	0.000
K46 Unspecified abdominal hernia	0.000	0.998	0.002
M89 Other disorders of bone	0.000	0.998	0.002
L91.8 Other hypertrophic disorders of skin	0.000	0.998	0.002
I49.0 Ventricular fibrillation and flutter	0.000	0.998	0.002
E13 Other specified diabetes mellitus	0.002	0.998	0.000
M34.2 Systemic sclerosis induced by drugs and chemicals	0.002	0.998	0.000
M34.0 Progressive systemic sclerosis	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.002	0.998	0.000
H35.2 Other proliferative retinopathy	0.002	0.998	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.998	0.002
E87.7 Fluid overload	0.002	0.998	0.000
R06.4 Hyperventilation	0.000	0.998	0.002
I74 Arterial embolism and thrombosis	0.002	0.998	0.000
W44 Foreign body entering into or through eye or natural orifice	0.002	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.002	0.998	0.000
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.000	0.998	0.002
I74.9 Embolism and thrombosis of unspecified artery	0.002	0.998	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.002	0.998	0.000
E14.6 With other specified complications	0.002	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.002	0.998	0.000
E14.2 Withrenal complications	0.002	0.998	0.000
L08.1 Erythrasma	0.002	0.998	0.000
M89.8 Other specified disorders of bone	0.000	0.998	0.002
D60 Acquired pure red cell aplasia [erythroblastopenia]	0.002	0.998	0.000
M25.31 Other instability of joint (Shoulder region)	0.000	0.998	0.002
M89.04 Algoneurodystrophy (Hand)	0.000	0.998	0.002
M89.3 Hypertrophy of bone	0.000	0.998	0.002
E14.4 With neurological complications	0.002	0.998	0.000
K11.2 Sialoadenitis	0.002	0.998	0.000
M25.37 Other instability of joint (Ankle and foot)	0.000	0.998	0.002
E14.1 With ketoacidosis	0.002	0.998	0.000
Z01.4 Gynaecological examination (general)(routine)	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.998	0.002
H35.9 Retinal disorder, unspecified	0.002	0.998	0.000
K46.1 Unspecified abdominal hernia with gangrene	0.000	0.998	0.002
Z85.6 Personal history of leukaemia	0.000	0.998	0.002
E14.0 With coma	0.002	0.998	0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)	0.002	0.998	0.000
M89.38 Hypertrophy of bone (Other)	0.000	0.998	0.002
Z09.0 Follow-up examination after surgery for other conditions	0.000	0.998	0.002
C50.5 Lower-outer quadrant of breast	0.002	0.998	0.000
M89.6 Osteopathy after poliomyelitis	0.000	0.998	0.002
M89.2 Other disorders of bone development and growth	0.000	0.998	0.002
M89.1 Epiphyseal arrest	0.000	0.998	0.002
N30.1 Interstitial cystitis (chronic)	0.000	0.998	0.002
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.002	0.998	0.000
G24.9 Dystonia, unspecified	0.000	0.998	0.002
L89.2 Stage III decubitus ulcer	0.002	0.998	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.002	0.998	0.000
W44.2 School, other institution and public administrative area	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.000	0.998	0.002
E13.8 With unspecified complications	0.002	0.998	0.000
E13.7 With multiple complications	0.002	0.998	0.000
E13.6 With other specified complications	0.002	0.998	0.000
E13.5 With peripheral circulatory complications	0.002	0.998	0.000
E13.4 With neurological complications	0.002	0.998	0.000
E13.2 With renal complications	0.002	0.998	0.000
E13.1 With ketoacidosis	0.002	0.998	0.000
E13.0 With coma	0.002	0.998	0.000
E14.7 With multiple complications	0.002	0.998	0.000
L91.9 Hypertrophic disorder of skin, unspecified	0.000	0.998	0.002
W44.9 Unspecified place	0.002	0.998	0.000
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.998	0.002
M89.09 Algoneurodystrophy (Site unspecified)	0.000	0.998	0.002
I74.8 Embolism and thrombosis of other arteries	0.002	0.998	0.000
E14.8 With unspecified complications	0.002	0.998	0.000
E14.5 With peripheral circulatory complications	0.002	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.000	0.998	0.002
T21.2 Burn of second degree of trunk	0.002	0.998	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.998	0.002
H68 Eustachian salpingitis and obstruction	0.000	0.998	0.002
H67 Otitis media in diseases classified elsewhere	0.000	0.998	0.002
W44.5 Trade and service area	0.002	0.998	0.000
W44.7 Farm	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations